← Leaderboards
Oljora Rezhdo
Mechasim Inc.
$125,658
Attributed
$251,316
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$251,316 · 1
By mechanism
R43$251,316 · 1
Top collaborators
- Rebecca L Carrier1 shared
Others in their field
Other Emerging Leaders on “Adverse Effects”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Kristin Aillon · Midwest Research Institute$23,644,534
- Abraham Aizer Brody · New York University School Of Medicine$21,887,280
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
Research focus
Adverse EffectsAlgorithmsAppropriate DoseAqueousAreaBaseBioavailableBiological AvailabilityBusinessesCanis FamiliarisCapsuleColloidsCommercializationCompliance BehaviorComputer ModelsDeglutitionDesignDiarrheaDigestionDosage FormsDoseDrug Delivery SystemsDrug DevelopmentAbsorption